Lifesign COVID-19/Flu A&B test
Infections with these viruses may present similar symptoms. Can you tell them apart?
We can.
Lifesign COVID-19/Flu A&B Test
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from nasopharyngeal swab specimens.
As an intended point-of-care (POC) designated test performed by medical professionals Lifesign COVID-19/Flu A&B test helps provide critical answers about active infections to patients and healthcare workers alike.
COVID-19
Lifesign COVID-19/Flu A&B Test
A Rapid Point of Care Test
- Sensitivity and Specificity
− COVID-19 – Sensitivity 93.9%, Specificity 100%
− Flu A – Sensitivity 91.4%, Specificity 95.7%
− Flu B – Sensitivity 87.6%, Specificity 95.9% - FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
Flu A
Flu A Sensitivity
91.4%
Specificity
95.7%
COVID Clinical Evaluation
COVID-19 Sensitivity
93.9%
Specificity
100%
Kit Components
- 25 Test devices
- 1 Instruction for Use